stoxline Quote Chart Rank Option Currency Glossary
  
TRxADE HEALTH, Inc. (MEDS)
9.1  -0.03 (-0.33%)    06-21 16:00
Open: 8.88
High: 9.1
Volume: 69,072
  
Pre. Close: 9.13
Low: 8.04
Market Cap: 13(M)
Technical analysis
2024-06-21 4:53:49 PM
Short term     
Mid term     
Targets 6-month :  13.1 1-year :  15.3
Resists First :  11.22 Second :  13.1
Pivot price 7.3
Supports First :  7.62 Second :  5.4
MAs MA(5) :  8.75 MA(20) :  7
MA(100) :  9.18 MA(250) :  8.03
MACD MACD :  0.5 Signal :  0.1
%K %D K(14,3) :  64.7 D(3) :  65.6
RSI RSI(14): 65.4
52-week High :  44.56 Low :  3.69
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MEDS ] has closed below upper band by 13.4%. Bollinger Bands are 49.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 47 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.11 - 9.16 9.16 - 9.2
Low: 7.93 - 7.99 7.99 - 8.03
Close: 9 - 9.1 9.1 - 9.18
Company Description

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Headline News

Tue, 20 Feb 2024
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace

Fri, 16 Feb 2024
Trxade Group Divests Assets, Refocuses Pharmaceutical Strategy - TipRanks.com - TipRanks

Mon, 12 Feb 2024
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary - AlphaStreet

Wed, 04 Oct 2023
Superlatus acquires Spero Foods' assets (NASDAQ:MEDS) - Seeking Alpha

Thu, 07 Sep 2023
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 ... - Yahoo Finance

Mon, 04 Sep 2023
MEDS Stock Quote Price and Forecast - CNN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Pharmaceuticals
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 507970 (%)
Held by Institutions 63.9 (%)
Shares Short 21 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -7.24e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -215.8 %
Operating Margin -263.3 %
Return on Assets (ttm) -56 %
Return on Equity (ttm) -3 %
Qtrly Rev. Growth 8.27e+006 %
Gross Profit (p.s.) 2.03
Sales Per Share 47.35
EBITDA (p.s.) 0
Qtrly Earnings Growth -18 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0.19
Price to Cash Flow 32
Stock Dividends
Dividend 0
Forward Dividend 10640
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android